EYE201/MK-8748
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EYE201/MK-8748, covering 2026-04-23 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) [Phase 2, Phase 3]